Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells

Journal of Cellular Physiology

Volumn 221, Issue 1, 2009, Pages 189-194

  Cascio, Sandra ^a   Ferla, Rita ^a,b   D'Andrea, Aleco ^a   Gerbino, Aldo ^c   Bazan, Viviana ^a   Surmacz, Eva ^b   Russo, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b TEMPLE UNIVERSITY   (United States)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LEPTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA; STAT3 PROTEIN; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE CONTROL; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SYNTHESIS; ANGIOGENESIS; CELL NUCLEUS; CELL STRAIN HT29; COLORECTAL TUMOR; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL NUCLEUS; COLORECTAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HT29 CELLS; HUMANS; LEPTIN; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69249227496     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21843     Document Type: Article

References (43)

1. Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA. 2006. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor. Cancer Res 66:3162-3168.
2. Amemori S, OotaniA, Aoki S, Fujise T, Shimoda R, Kakimoto T, Shiraishi R, Sakata Y, Tsunada S, Iwakiri R, Fujimoto K. 2007. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiol Gastrointest Liver Physiol 292:G923-G929.
3. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A, Polychronidis A, Simopoulos C. 2008. Human leptin induces angiogenesis in vivo. Cytokine 42:353-357.
4. Aparicio T, Guilmeau S, Goiot H, Tsocas A, Laigneau JP, Bado A, Sobhani I, Lehy T. 2004. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. Gastroenterology 126:499-510. (Pubitemid 38182307)
5. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C. 2000. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 14:2329-2338. (Pubitemid 30843929)
6. Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E. 2008. Insulin-dependent leptin expression in breast cancer cells. Cancer Res 68:4919-4927.
7. Brenneisen P, Blaudschun R, Gille J, Schneider L, Hinrichs R, Wlaschek M, Eming S, Scharffetter-Kochanek K. 2003. Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem J 369:341-349. (Pubitemid 36174203)
8. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. 2001. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98:6390-6395. (Pubitemid 32488247)
9. Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, LanzinoM,De Amicis F, Ando S. 2009. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. J Cell Physiol 218:490-500.
10. Ciardiello F, Tortora G. 2001. A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptor. Clin Cancer Res 7:2958-2970. (Pubitemid 32963812)
11. Cong L, Chen K, Li J, Gao P, Li Q, Mi S, WuX, Zhao AZ. 2007. Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes. Biochem J 403:519-525. (Pubitemid 46706980)
12. Ferrara N, Kerbel RS. 2005. Angiogenesis as a therapeutic target. Nature 438:967-974.
13. FinkenzellerG, Sparacio A, TechnauA,MarmeD, SiemeisterG. 1997. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15:669-676.
14. Folkman J. 1971. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186.
15. Frank DA. 2007. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 251:199-210.
16. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S, Surmacz E. 2006. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli. Clin Cancer Res 12:1447-1453.
17. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR. 2006. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281:26320-26328. (Pubitemid 44401840)
18. Housa D, Housova J, Vernerova Z, Haluzik M. 2006. Adipocytokines and cancer. Physiol Res 55:233-244.
19. Jaffe T, Schwartz B. 2008. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123:2543-2556.
20. Kang J, Rychahou PG, Ishola TA, Mourot JM, Evers BM, Chung DH. 2008. N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma. Oncogene 27:3999-4007. (Pubitemid 351913633)
21. Klampfer L. 2008. The role of signal transducers and activators of transcription in colon cancer. Front Biosci 13:2888-2899. (Pubitemid 351589205)
22. Koda M, Sulkowska M, Kanczuga-Koda L, Cascio S, ColucciG, Russo A, Surmacz E, Sulkowski S. 2007. Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer. Ann Oncol 18:vi116-vi119.
23. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004. (Pubitemid 32476461)
24. Logan-Collins JM, Lowy AM, Robinson-Smith TM, Kumar S, Sussman JJ, James LE, Ahmad SA. 2008. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol 15:738-744.
25. Maity A, Pore N, Lee J, Solomon D, O'Rourke DM. 2000. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia. Cancer Res 60:5879-5886. (Pubitemid 30808327)
26. Mason MM, He Y, Chen H, Quon MJ, Reitman M. 1998. Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. Endocrinology 139:1013-1022. (Pubitemid 28510118)
27. Mendelsohn J, Baselga J. 2000. The EGF receptor family as targets for cancer therapy. Oncogene 19:6550-6565. (Pubitemid 32197693)
28. Misztal-Dethloff B, Stepien H, Komorowski J. 2004. Effect of leptin on proliferative activity and vascular endothelial growth factor (VEGF) secretion from cultured endothelial cells HECa10 in vitro. Endocr Regul 38:161-166. (Pubitemid 43001070)
29. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. 2002. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008.
30. PoreN, Liu S, Haas-Kogan DA, O'Rourke DM, Maity A. 2003. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter. Cancer Res 63:236-241. (Pubitemid 36070445)
31. Pore N, Jiang Z, Gupta A, Cerniglia G, Kao GD, Maity A. 2006. EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1- independent and HIF-1-dependent mechanisms. Cancer Res 66:3197-3204.
32. Santra M, Santra S, Zhang J, Chopp M. 2008. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3. J Neurochem 105:324-337.
33. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA. 2007. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67:2497-2507. (Pubitemid 46548934)
34. Seidel HM, Milocco LH, Lamb P, Darnell JE, Jr., Stein RB, Rosen J. 1995. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92:3041-3045.
35. Suganami E, Takagi H, OhashiH, Suzuma K, Suzuma I, Oh H, WatanabeD,Ojima T, Suganami T, Fujio Y, Nakao K, Ogawa Y, Yoshimura N. 2004. Leptin stimulates ischemia-induced retinal neovascularization: Possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 53:2443-2448. (Pubitemid 39145601)
36. Tong KM, Shieh DC, Chen CP, Tzeng CY, Wang SP, Huang KC, Chiu YC, Fong YC, Tang CH. 2008. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts. Cell Signal 20:1478-1488.
37. Vigneron A, Gamelin E, Coqueret O. 2008. The EGFR-STAT3 oncogenic pathway upregulates the Eme1 endonuclease to reduceDNAdamage after topoisomerase I inhibition. Cancer Res 68:815-825. (Pubitemid 351206759)
38. WautersM, Considine RV, Van Gaal LF. 2000. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143:293-311.
39. WeiD, Le X, Zheng L, Wang L, Frey JA,Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. 2003. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22:319-329. (Pubitemid 36194328)
40. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX, Fang JY. 2008. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10:287-297. (Pubitemid 351328587)
41. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, YuH. 2005. Targeting Stat3 blocks bothHIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24:5552-5560.
42. Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A, Kombouras C. 2008. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res 147:99-107. (Pubitemid 351626074)
43. Zhong H, Chiles K, Feldser D, Laughner E,Hanrahan C, Georgescu MM, Simons JW, Semenza GL. 2000. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541-1545. (Pubitemid 30183422)